Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.
What can federal health agencies do to revive the fading trust of the public?
Confidence in public health entities is spiraling downward in the U.S., and once-revered Washington institutions like the CDC and NIH are among the casualties in serious condition. How to break the negative momentum?
Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data
The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.
AAP, other physician societies double down on Kennedy-crossing vaccination stance
5 high-profile physician leaders: ‘Misinformation, politicization of commonsense public health efforts and sudden changes to federal vaccine guidance are creating mass confusion and diminishing trust in public health.’

overnight night shift attending radiologist burnout

Researchers take a fresh look at how different risk factors impact the look of a patient's heart

The study included cardiac MRI scans of nearly 30,000 patients.

FDA authorizes Pfizer’s COVID-19 pill

Paxlovid becomes the first treatment for the coronavirus taken in pill form, the federal agency announced.

COVID-19 vaccines tied to greater risk of myocarditis or myopericarditis—but specialists highlight the benefits of vaccination

The new analysis focused on nearly 5 million individuals who received either the Moderna or Pfizer/BioNTech vaccine.

Premature heart attack deaths more common among Black, male and rural patients

Researchers tracked data from more than 600,000 patient deaths in the United States, sharing their findings in the Journal of the American Heart Association.

Apixaban linked to lower bleeding risk than rivaroxaban for patients with nonvalvular AFib

A new meta-analysis compared outcomes associated with the two popular DOACs.

Biden administration announces new actions to help hospitals keep up with omicron

The feds are making a large push to expand testing, setting up new sites across the U.S. and sending 500 million free kits to Americans beginning Jan. 1.

An industry first: FDA authorizes marketing of laser-assisted IVC filter removal device

The Philips CavaClear Laser Sheath earned the agency’s breakthrough device designation back in July.

FDA approves rivaroxaban for treating, preventing blood clots in pediatric patients

The direct oral anticoagulant is now approved for 11 different indications.

Clinical

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

What can federal health agencies do to revive the fading trust of the public?

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

AAP, other physician societies double down on Kennedy-crossing vaccination stance